“Authorized” Generics Will Be Subject To “Best Price” Calculations – CMS

The Centers for Medicare & Medicaid Services is indicating that it will consider "authorized" generics to be brand drugs for the purposes of best price reporting

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet